pe2228 vs dihexa (PNB-0408) | Angiotensin IV analogue | CAS NO.:1401708-83-5 PE-22-28 - Peptide Affect
PE 22 28 Peptide Affect Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non Small Cell Lung Cancer Models ACS Pharmacology & Translational Science Dihexa (PNB 0408) C27H44N4O5 CID 125355097 PubChem Pe 2228 Peptide Review TikTok
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
